The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's

NCT03649724 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Mild Cognitive Impairment

Interventions

DRUG: Placebo
DRUG: Eligard 22.5Mg Suspension for Injection

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]
[object Object]